People like you are transforming their lives, feeling better and looking their best with the help of GLP-1 medications
These individual differences are usually small enough that they dont require dose adjustments or modified dosing schedules
Skin elasticity presents another concern

Research chemical retatrutide use (risky) Important disclaimer: Retatrutide NOT FDA approved NOT legally available outside clinical trials Research chemical market offers it Quality, purity, authenticity highly questionable No guarantee you're getting retatrutide Could be underdosed, impure, or wrong compound Use at own risk Research chemical dosing (reported): Conservative approach: Start 0.5mg weekly (lower than trial) Increase 0.5mg every 4 weeks Target 4-8mg weekly Don't exceed 12mg Track side effects carefully Reported protocols: Why research chemical use is risky: Unknown compound identity (could be anything labeled "retatrutide") Underdosing (diluted or mislabeled) Overdosing (dangerously concentrated) Impurities (toxic contaminants) No regulatory oversight (zero quality control) Legal gray area (not approved for human use) If using research chemicals despite risks: Buy from established vendors (relative term, still risky) Request third-party testing (COA) Start very low dose Increase slowly Monitor for any concerning symptoms Accept you're experimenting on yourself Better alternatives while waiting for FDA approval: Tirzepatide (FDA approved, 20-22% loss) Semaglutide (FDA approved, 15% loss) CagriSema (in trials, may get approval sooner) Join retatrutide clinical trial (free, supervised) See are peptides legal and common mistakes guides

The semaglutide dosage calculator and peptide calculator on SeekPeptides can help researchers determine appropriate dosing for their specific protocols
The scale is not linear